foro 10 Access – foro 10 Access

The space where Market Access experts meet

Don't miss the forum 10access

Here we will discuss relevant experiences, ideas and insights on the importance of this discipline; its implementation, advantages and challenges within the pharmaceutical sector and health systems in Latin America

First

forum 10access

On this occasion we had the pleasure of bringing together …

Catalina Bello

Economist from the Rosario University, specializing in economic law and markets. She has more than 16 years of experience in the pharmaceutical and union sector. She is currently the director of access and sustainability of AFIDRO.

Luz Andrea Ramírez

Doctor from the Javeriana University with a master’s degree in public health and management. She has 11 years of experience in the pharmaceutical industry, and has led teams in medical affairs. She currently serves as the medical director of AMGEN Colombia.

Yira Diaz

Microbiologist with a master’s degree in biological sciences and a specialization in health economics. Leader in public affairs and market access with wide experience in public policy, access, corporate sustainability, value in health and communications. Most recently, she has served as Director of Corporate Affairs & Market Access for Roche Products Colombia.

These three recognized Market Access leaders within the pharmaceutical sector discuss their different perspectives on Market Access in our region. Do not miss the analysis, conclusions and insights that will be invaluable for your professional growth

Recording date: December 2020

Session 1

Do you consider that within a pharmaceutical company, Market Access (MA) knowledge should be transversal to other areas such as medical, commercial, marketing and public affairs?

Session 2

Which of the following MA topics do you consider to be the one that people in the industry know the least about?

Session 3

Which of the following MA topics do you consider to be the one that people in the industry know the most?

Session 4

To be successful in executing an MA plan, how important is it to have negotiation skills?

Session 5

After the Market Access department, the area that you should know the most about this topic (MA) is:

Second

forum 10access

On this occasion we had the pleasure of bringing together …

Diana Téllez

Doctor from the National University of Colombia, with a master’s degree in public health from the University of Warwick in the United Kingdom and a doctorate in business administration (DBA) from the International School of Management in Paris. Extensive experience in market access, government and public affairs, health economics and relationships with patient organizations in the pharmaceutical and medical device industry (more than 10 years).

Ana María Vesga

A lawyer from the University of Los Andes with a specialization in senior management and strategic leadership, she has 15 years of experience in the energy and oil sector. For the last 3 years she has been involved with ANDI as executive director of the pharmaceutical chamber, an organization that brings together 67 laboratories of national and multinational production that represent 82% of the pharmaceutical market in the country.

Jimena Bernal

Industrial engineer with a master’s degree in health administration. She is currently responsible for preparing launches for Novartis in the Andean cluster. She has 15 years of experience in the pharmaceutical industry, and has been involved in different roles in the launch of more than 10 brands.

Recording date: December 2020

Session 1

Do you consider that within a pharmaceutical company, Market Access (MA) knowledge should be transversal to other areas such as medical, commercial, marketing and public affairs?

Session 2

Which of the following MA topics do you consider to be the one that people in the industry know the least about?

Session 3

Which of the following MA topics do you consider to be the one that people in the industry know the most?

Session 4

To be successful in executing an MA plan, how important is it to have negotiation skills?

#TodosSomosMarketAccess #10Access

KNOW MARKET ACCESS

It is not something just for the access manager.

It is for everyone involved in entering and maintain a pharmaceutical product or or device on the market, SUCCESSFUL

Learn to design and implement successful market access strategies